238000000342 Monte Carlo simulation Methods 0.000 abstract description 44.238000006011 modification reaction Methods 0.000 claims description 8.230000004048 modification Effects 0.000 claims description 8.238000001514 detection method Methods 0.000 claims description 8.239000004926 polymethyl methacrylate Substances 0.000 claims description 10.229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 10.210000000988 Bone and Bones Anatomy 0.000 claims description 10.238000004364 calculation method Methods 0.000 claims description 42.XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 80.210000003205 Muscles Anatomy 0.000 claims abstract description 90.238000003860 storage Methods 0.000 title abstract description 28.238000005538 encapsulation Methods 0.000 title abstract description 44.238000002725 brachytherapy Methods 0.000 title claims abstract description 242.238000004980 dosimetry Methods 0.000 title claims abstract description 266.HGLDOAKPQXAFKI-OUBTZVSYSA-N californium-252 Chemical compound HGLDOAKPQXAFKI-OUBTZVSYSA-N 0.000 title claims abstract description 478.Priority to US10/420,184 priority patent/US7118524B2/en Publication of US6551232B1 publication Critical patent/US6551232B1/en Application granted granted Critical Priority to US11/540,432 priority patent/US20070084474A1/en Anticipated expiration legal-status Critical Status Expired - Fee Related legal-status Critical Current Links ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). reassignment NEW ENGLAND MEDICAL CENTER HOSPITALS, INC. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US14981699P external-priority Application filed by New England Medical Center Hospitals Inc filed Critical New England Medical Center Hospitals Inc Priority to US09/641,356 priority Critical patent/US6551232B1/en Priority to EP00959273A priority patent/EP1210148A2/en Priority to AU70623/00A priority patent/AU7062300A/en Priority to PCT/US2000/022762 priority patent/WO2001012263A2/en Assigned to NEW ENGLAND MEDICAL CENTER HOSPITALS, INC. ![]() Original Assignee New England Medical Center Hospitals Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Rivard Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Fee Related Application number US09/641,356 Inventor Mark J. Google Patents Dosimetry for californium-252(252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereofÄownload PDF Info Publication number US6551232B1 US6551232B1 US09/641,356 US64135600A US6551232B1 US 6551232 B1 US6551232 B1 US 6551232B1 US 64135600 A US64135600 A US 64135600A US 6551232 B1 US6551232 B1 US 6551232B1 Authority US United States Prior art keywords neutron dose source dosimetry sources Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US6551232B1 - Dosimetry for californium-252(252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof US6551232B1 - Dosimetry for californium-252(252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |